Clinical Study
Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
Table 9
Insulin resistance according to different criteria.
| | Group 1 | Group 2 | Group 3 | | Obese | Lean PCOS | Obese PCOS | | () | () | () | | n | | n | | n | |
| IFG/IGT | 6 | 10.7% | 5 | 8.9% | 9 | 20.9% | Increased baseline insulin | 28 | 50.0% | 5 | 8.9% | 29 | 67.4% | Elevation of IRI over 100 mU/L on the 60 min of OGTT | 26 | 46.4% | 9 | 16.1% | 27 | 62.8% | Elevation of IRI over 100 mU/L on the 120 min of OGTT | 12 | 21.4% | 5 | 8.9% | 11 | 25.5% | Elevation of IRI over 100 mU/L on the 60 and/or 120 min of OGTT | 29 | 51.8% | 10 | 17.9% | 27 | 62.8% | Elevation of IRI over 100 mU/L on the 60 and 120 min of OGTT | 9 | 16.1% | 4 | 7.1% | 11 | 25.6% | Elevation of IRI more than 5 times over the baseline (%) | 39 | 69.6% | 40 | 71.4% | 29 | 67.4% | Decreased baseline glucose/insulin ratio (< 0.333 mmol/L/mU/L) | 30 | 53.6% | 12 | 21.4% | 29 | 67.4% | Increased HOMA-index | 39 | 69.6% | 17 | 30.4% | 37 | 86.0% |
|
|